Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulaglutide vs Liraglutide in obese adolescents with type 2 diabetes
NCT04829903Completed
- Sponsor
- Hospital Universitari Parc Taulí
- Start
- Jan 2020
- Primary completion
- Mar 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Randomised, double-blind trial of dulaglutide in type 2 diabetes mellitus (T2DM), sponsored by Hospital Universitari Parc Taulí. Primary endpoints: Glycemic level at 24 weeks and Body Mass Index at 24 weeks. Started Jan 2020; status: completed.
02
Drugs
dulaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04829903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04829903.